Report Highlights
Report Includes
- Identification of the top 10 companies in telemedicine technologies and the rationale behind these selections.
- Factors that include technical innovation, market leadership, and commitment to this market via investment in products.
When selecting these top 10 companies, BCC Research looked across the industry spectrum and selected the most active and significant contributors while recognizing that there are many other contenders. Some of these “significant others” are included but to a less detailed extent than the top 10 companies.
INTRODUCTION
Today, healthcare is one of the top economic and social problems across the globe. Put simply, the problem comes down to two factors: accessibility and affordability. Here in America, it is reported that U.S. citizens spend twice as much as citizens of other developed countries. However, citizens in the U.S. also report lower quality, efficiency and access of service than citizens in those same developed countries.
Globally, there is an increasing aging population plagued with chronic disease. These factors, combined with a focus on prevention and advancements in technologies, pharmaceuticals and treatments, will undoubtedly cause demand for healthcare services to continue to increase into the future.
REASONS FOR THE STUDY
There has been a global focus on the use of telemedicine as a tool to cut down healthcare costs and bring about mammoth savings. Implementation of the new U.S. healthcare law will, if anything, intensify this focus by increasing the number of people who have health insurance and are seeking medical services. In the near to mid-term, telemedicine technologies offer one of the few ways of enabling healthcare personnel to meet the increased demand without unacceptable delays or other forms of de facto rationing.
There is interest in studying the ways in which collaborative healthcare can be better and more economically implemented through telemedicine. Recently announced best practices to cut down global healthcare costs, including outsourced medical services, home-based treatment, intervention as opposed to post treatment, integrated information technology (IT) environments, increased efficiency of healthcare resources and reducing billing gaps, all point toward the increasing use of telemedicine.
Given these factors, it seems timely that BCC identify the top 10 companies in the telemedicine field and the key factors to success in the telemedicine market that these companies are exploiting.
The report will also help gauge the ways in which this market can significantly affect larger markets such as healthcare, health insurance, home care, telecommunications (telecom), networking, disease management, e-health and healthcare IT. This is also timely, as major tier-one stakeholders are starting to enter the telemedicine market.
STUDY GOALS AND OBJECTIVES
This document is a specialty report related to the BCC Research report HLC014E authored by Andrew McWilliams. The goal of this document is to provide a more in-depth look at the top-tier telemedicine companies as well as some of the second-tier companies to look for in the near future.
Key criteria used to determine top players in the field include:
- Financial standing.
- Established market presence.
- Positioning within the healthcare ecosystem.
- Company track record of deliverable solutions.
- End-to-end coverage vs. niche market solution.
- Parent and subsidiary company support.
- Intellectual property and strategic licensing portfolio.
In addition to this these factors that BCC has chosen to examine, BCC has selected these 10 companies for this report that it feels are deserving of recognition, and are leaders in their industry. This list includes:
- Alcatel-Lucent.
- AMD Telemedicine Inc.
- Cardiocom.
- Cisco.
- Honeywell Hommed.
- International Business Machines Corp.
- LifeWatch AG.
- Polycom.
- Robert Bosch Healthcare.
- SHL Telemedicine Ltd.
As any top-10 list is invariably subjective, there are also several companies profiled in less detail. These companies were on the bubble or should be watched in the near future, as they are currently on the rise.
INTENDED AUDIENCE
This report is intended for telemedicine hardware manufacturers, software providers, telecom and networking companies, the healthcare industry and healthcare insurance companies. The report should also be of interest to those interested in entering the telemedicine market or to those looking to merge with, partner with or buy out existing players in the field.
SCOPE
The scope of this report is focused on a select 10 companies in telemedicine and the key areas in the field that are driving industry growth and allowing these companies to succeed. These areas include home health care services, monitoring services, medical devices and communications solutions.
METHODOLOGY
Based on primary and secondary market analysis, this report analyzes the top 10 companies in telemedicine as well as some additional companies worth recognizing.
BCC ON-LINE SERVICES
BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:
- Examine the complete BCC Research catalog of market research reports and place direct orders.
- Subscribe to any of BCC Research’s many industry newsletters.
- Read announcements of recently published reports and newly launched newsletters.
- Register for its well-known conferences.
- Request additional information on any BCC research product.
- Take advantage of special offers.
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Related Reports
Recent Reports
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More